Form 4 for TCRT Alaunos Therapeutics, Inc.
Accepted 2025-07-07 00:00:00 ET · period of report 2025-07-03 · accession 0000950170-25-094387 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-07 | 2025-07-03 | TCRT | Postma Robert W | Dir | A - Grant | $0.00 | +4,050 | 33.1K | +14% | $0 |
| D | 2025-07-07 | 2025-07-03 | TCRT | Postma Robert W | Dir | A - Grant | $0.00 | +6,400 | 6,400 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-03 | A | A | 4,050 | $0.00 | 33,133 | D | — | — | (F1) Represents a grant of restricted stock units (RSUs) which immediately vested upon grant. After the reported acquisition of the RSUs, the reporting person owned in aggregate 33,133 shares of common stock (29,083 previously owned shares, plus the instant grant of 4,034 RSUs). |
| 2 | Derivative | Employee Stock Option (right to buy) | 2025-07-03 | A | A | 6,400 | $0.00 | 6,400 | D | $5.00 · — to 2035-07-03 | 6,400 Common Stock | (F3) One-twelfth of the Option vests each month on the monthly anniversary of July 3, 2025, with any amount that remains unvested on the date immediately preceding the Company's 2026 annual general meeting of stockholders vesting thereon. |